Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study-Reference-Cited by-同舟云学术

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

Published:2019-04 Issue:10179 Volume:393 Page:1453-1464
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Carrat Fabrice,Fontaine Hélène,Dorival Céline,Simony Mélanie,Diallo Alpha,Hezode Christophe,De Ledinghen Victor,Larrey Dominique,Haour Georges,Bronowicki Jean-Pierre,Zoulim Fabien,Asselah Tarik,Marcellin Patrick,Thabut Dominique,Leroy Vincent,Tran Albert,Habersetzer François,Samuel Didier,Guyader Dominique,Chazouilleres Olivier,Mathurin Philippe,Metivier Sophie,Alric Laurent,Riachi Ghassan,Gournay Jérôme,Abergel Armand,Cales Paul,Ganne Nathalie,Loustaud-Ratti Véronique,D'Alteroche Louis,Causse Xavier,Geist Claire,Minello Anne,Rosa Isabelle,Gelu-Simeon Moana,Portal Isabelle,Raffi François,Bourliere Marc,Pol Stanislas

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa;Fontaine;Lancet,2000

2. Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more;Pearlman;Clin Infect Dis,2011

3. Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis;Cheung;J Hepatol,2016

4. Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population;Innes;J Hepatol,2017

5. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents;Kanwal;Gastroenterology,2017

Cited by 470 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study;Viruses;2024-09-10

2. m⁶A‐Dependent ITIH1 Regulated by TGF‐β Acts as a Target for Hepatocellular Carcinoma Progression;Advanced Science;2024-09-05

3. Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review;Expert Opinion on Pharmacotherapy;2024-08-12

4. The effect of sudden fluctuations on a treated Hepatitis C model;International Journal of Biomathematics;2024-08-10

5. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside;Experimental Hematology & Oncology;2024-08-01